This is a reverberating cycle post. Seems to appear with regularity as the stock drops.....and drops.....and drops...and??? Now we may get what is perceived as good news eventually and when we do it will jump a bit and all the defenders will say what do you think of Jack now. and of course the fact that it dropped from $13 to penny territory means nothing as long as two or three times a year it jumps $.30-.40 before getting knocked down farther. This management team is awful and while they may be decent scientists (that's also an opinion not born out by fact) they are p-poor managers and are interested in only their personal gain,at the expense of the long time investors. and dam it, I'm one of the stupid ones!
sales and share price tend to support those who think something is not quite right with this company. Is that the clue that you reference that everyone thinks they have? .Perhaps question to ask is could this company be run any worse? I will digress as well and ditto you on your Christmas
try joining stockinvesting102. A yahoo group. well moderated,lots of opinion, good posters from many related fields.
you are correct but people do and will continue to. A nurse giving a shot takes less than 5 minutes so there will be no wait. And for $100 buck saving they'll take the drive (though I don't think this one will be cheap so perhaps moot) There was a tv show, Hillstreet Blues. some of you older folks will remember. I'll never forget in one episode the female DA was prosecuting a black lad who killed someone. His pastor, a rather insightful person was trying to get the DA to drop the charges and not prosecute because the young man was brought up in the hood and was driven by his upbringing and environment. She refused to see his point not understanding why a pastor would want a murderer freed. He simply said. "Ms. Davenport, your problem is that you understand with your understanding." That is our problem as well here. We want to make points based on how we feel and we expect that everyone else has the same backgrounds and incentives. That's not the case. When your customers tells you what is preventing them from using your product and there is a reasonable and less expensive competitor the majority will choose the less expensive and not care about adverse events until they have one. Then they'll say all of them weight loss drugs are bad. And most will not have an adverse event.
vader, I am looking and listening to what patients are saying. And doctors. Having more indications for a drug that is not selling because of cost is meaningless. The competition grows. The only good thing about Saxenda is by increasing the dose and calling it a weight loss drug it will be more expensive as well, but endos already know it helps with weight loss at its' current dosage. now I know its' injectable but don't know how often it needs to be injected but I do see it as a nice source of revenue for docs who bring patients in just to have their nurse inject them and send them on their way . Short office visit charge, injection charge. We like to think this all about health. It's not. It's about cost to the insurance companies and consumer. belviq's price point was not vetted properly and the result is the share price and market share
ok, that I understand. So the extra paperwork claim was a misrepresentation of what's true and the abuse potential low. What is Contrave's schedule? I read from posters here that it has a black box???? Sounds ominous. What does that mean?
Thanks dork. I don't see a reference to suggest extra paperwork. Where am I missing the claim? Is lorcasein the same as belviq? How did the FDA allow 40 and 60 mg doses with this information?
OK Jack, you've managed to destroy any advantage you might have had by executing. Like you said, the share price will take care of itself.
I read this on every biotech/pharma board. Must be true. Wonder how they can do it under SEC's nose on hundreds of stocks.
watch for any credible reports that he can move his ankles up and down as in foot tapping and/or volitionally bend his knees. That will be a sign he's beyond what can be expected at this level injury given the info available so far.
This is in my field of orthopedic rehabilitation and I've often said (here) that orthopedic surgeons could/should be a source of prescription. Joint health is not just a function of direct compression from weight, in fact the body has mechanisms to strengthen bone and cartilage as more compression force is added overtime. Being overweight is also a sign of poor nutrition and imo, circulatory compromise from occlusion of the small arterioles that feed the tissue and cleanse joints from their metabolic waste. We are at a point where it's not what we know, it's how we use that knowledge to effect positive outcome on patients. This is now capable through the addition of pharmaceutical agents. Again the consumer will chose what is available with cost and out of pocket expense for product being the driving force when they have choice.
ed, I am not on nor do I know anyone personally taking Contave. And I live in Texas. I'm sharing what I read in the belviq support group and the trend is obvious. there are exceptions, here's one from the same thread: "I have no taken Contrave my doc was researching it, I just know one of the drugs in it is Wellbutrin anti depression med which I used to take, it made me feel very uptight, raised my bp, but never lost wt on it, I would rather stay on Belviq especially if it is working." One thing that should be clear to all is that until someone has a problem they will believe it can't happen to them and side with cost, especially if the dial on the scale is moving in the right direction